| Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ... Nature genetics 45 (4), 371-384, 2013 | 652 | 2013 |
| GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer PDP Pharoah, YY Tsai, SJ Ramus, CM Phelan, EL Goode, K Lawrenson, ... Nature genetics 45 (4), 362-370, 2013 | 425 | 2013 |
| Identification of six new susceptibility loci for invasive epithelial ovarian cancer KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ... Nature genetics 47 (2), 164-171, 2015 | 311 | 2015 |
| Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases F Heitz, P Harter, HJ Lueck, A Fissler-Eckhoff, F Lorenz-Salehi, ... European journal of cancer 45 (16), 2792-2798, 2009 | 298 | 2009 |
| Treatment of recurrent ovarian cancer S Pignata, SC Cecere, A Du Bois, P Harter, F Heitz Annals of Oncology 28, viii51-viii56, 2017 | 283 | 2017 |
| PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS MC Southey, DE Goldgar, R Winqvist, K Pylkäs, F Couch, M Tischkowitz, ... Journal of medical genetics 53 (12), 800-811, 2016 | 243 | 2016 |
| Impact of a structured quality management program on surgical outcome in primary advanced ovarian cancer P Harter, ZM Muallem, C Buhrmann, D Lorenz, C Kaub, R Hils, ... Gynecologic oncology 121 (3), 615-619, 2011 | 239 | 2011 |
| Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase JP Grabowski, P Harter, F Heitz, E Pujade-Lauraine, A Reuss, ... Gynecologic oncology 140 (3), 457-462, 2016 | 207 | 2016 |
| Genome-wide meta-analyses of breast, ovarian, and prostate cancer association studies identify multiple new susceptibility loci shared by at least two cancer types SP Kar, J Beesley, A Amin Al Olama, K Michailidou, J Tyrer, ZS Kote-Jarai, ... Cancer discovery 6 (9), 1052-1067, 2016 | 195 | 2016 |
| Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer H Shen, BL Fridley, H Song, K Lawrenson, JM Cunningham, SJ Ramus, ... Nature communications 4 (1), 1628, 2013 | 184 | 2013 |
| Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery B Ataseven, A du Bois, A Reinthaller, A Traut, F Heitz, S Aust, S Prader, ... Gynecologic oncology 138 (3), 560-565, 2015 | 172 | 2015 |
| Neoadjuvant chemotherapy in advanced ovarian cancer: on what do we agree and disagree? I Vergote, A du Bois, F Amant, F Heitz, K Leunen, P Harter Gynecologic oncology 128 (1), 6-11, 2013 | 167 | 2013 |
| Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1) P Harter, J Hauke, F Heitz, A Reuss, S Kommoss, F Marmé, A Heimbach, ... PloS one 12 (10), e0186043, 2017 | 164 | 2017 |
| Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium CM Nagle, SC Dixon, A Jensen, SK Kjaer, F Modugno, A DeFazio, ... British journal of cancer 113 (5), 817-826, 2015 | 164 | 2015 |
| Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21. 31 J Permuth-Wey, K Lawrenson, HC Shen, A Velkova, JP Tyrer, Z Chen, ... Nature communications 4 (1), 1627, 2013 | 142 | 2013 |
| ABCA Transporter Gene Expression and Poor Outcome in Epithelial Ovarian Cancer EL Hedditch, B Gao, AJ Russell, Y Lu, C Emmanuel, J Beesley, ... JNCI: Journal of the National Cancer Institute 106 (7), dju149, 2014 | 136 | 2014 |
| Shared heritability and functional enrichment across six solid cancers X Jiang, HK Finucane, FR Schumacher, SL Schmit, JP Tyrer, Y Han, ... Nature communications 10 (1), 431, 2019 | 122 | 2019 |
| Genome-wide significant risk associations for mucinous ovarian carcinoma Australian Ovarian Cancer Study Group, H Baker, EV Bandera, Y Bean, ... Nature genetics 47 (8), 888-897, 2015 | 118 | 2015 |
| Lavage of the uterine cavity for molecular detection of Müllerian duct carcinomas: a proof-of-concept study E Maritschnegg, Y Wang, N Pecha, R Horvat, E Van Nieuwenhuysen, ... Journal of Clinical Oncology 33 (36), 4293-4300, 2015 | 116 | 2015 |
| BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers HD Meeks, H Song, K Michailidou, MK Bolla, J Dennis, Q Wang, ... Journal of the National Cancer Institute 108 (2), djv315, 2016 | 105 | 2016 |
Philipp HarterEv. Kliniken Essen-Mitte, Essen, Germany在 kem-med.com 的电子邮件经过验证
